Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China · Delayed Price · Currency is CNY 30.57
-0.45 (-1.45%)
Jul 15, 2026, 3:00 PM CST
SHA:603334 Market Cap
SHA:603334 has a market cap or net worth of 4.45 billion as of July 14, 2026.
Market Cap
4.45B
Enterprise Value
3.79B
Revenue
3.61B
Ranking
n/a
PE Ratio
26.33
Stock Price
30.57
Market Cap Chart
Since November 5, 2025, SHA:603334's market cap has decreased from 9.58B to 4.45B, a decrease of -53.54%. That is a compound annual growth rate of -67.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 4.45B | -25.79% |
| Dec 31, 2025 | 6.00B | -37.39% |
| Nov 5, 2025 | 9.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| R&G PharmaStudies | 4.91B |
| Shenzhen Weiguang Biological Products | 4.72B |
| Hefei Lifeon Pharmaceutical | 4.70B |
| Wuhan Hvsen Biotechnology | 4.56B |
| ChemPartner PharmaTech | 4.46B |
| Shanghai Obio Technology (Group) Corp. | 4.23B |
| Shanghai Serum Bio-Technology | 4.20B |
| Kexing Biopharm | 4.12B |